HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maladaptive role of neutrophil extracellular traps in pathogen-induced lung injury.

Abstract
Neutrophils dominate the early immune response in pathogen-induced acute lung injury, but efforts to harness their responses have not led to therapeutic advancements. Neutrophil extracellular traps (NETs) have been proposed as an innate defense mechanism responsible for pathogen clearance, but there are concerns that NETs may induce collateral damage to host tissues. Here, we detected NETs in abundance in mouse models of severe bacterial pneumonia/acute lung injury and in human subjects with acute respiratory distress syndrome (ARDS) from pneumonia or sepsis. Decreasing NETs reduced lung injury and improved survival after DNase I treatment or with partial protein arginine deiminase 4 deficiency (PAD4+/-). Complete PAD4 deficiency (PAD4-/-) reduced NETs and lung injury but was counterbalanced by increased bacterial load and inflammation. Importantly, we discovered that the lipoxin pathway could be a potent modulator of NET formation, and that mice deficient in the lipoxin receptor (Fpr2-/-) produced excess NETs leading to increased lung injury and mortality. Lastly, we observed in humans that increased plasma NETs were associated with ARDS severity and mortality, and lower plasma DNase I levels were associated with the development of sepsis-induced ARDS. We conclude that a critical balance of NETs is necessary to prevent lung injury and to maintain microbial control, which has important therapeutic implications.
AuthorsEmma Lefrançais, Beñat Mallavia, Hanjing Zhuo, Carolyn S Calfee, Mark R Looney
JournalJCI insight (JCI Insight) Vol. 3 Issue 3 (02 08 2018) ISSN: 2379-3708 [Electronic] United States
PMID29415887 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Video-Audio Media)
Chemical References
  • Receptors, Formyl Peptide
  • formyl peptide receptor 2, mouse
  • Hydrolases
  • Deoxyribonuclease I
  • Protein-Arginine Deiminase Type 4
  • peptidylarginine deiminase 4, mouse
Topics
  • Animals
  • Bacteria (immunology)
  • Bacterial Load (drug effects, immunology)
  • Deoxyribonuclease I (administration & dosage)
  • Disease Models, Animal
  • Extracellular Traps (drug effects, immunology, metabolism)
  • Humans
  • Hydrolases (genetics, metabolism)
  • Lung Injury (drug therapy, immunology, microbiology, mortality)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Neutrophils (drug effects, immunology, metabolism)
  • Pneumonia, Bacterial (immunology, microbiology)
  • Protein-Arginine Deiminase Type 4
  • Receptors, Formyl Peptide (genetics, immunology, metabolism)
  • Respiratory Distress Syndrome (immunology, microbiology)
  • Sepsis (immunology, microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: